UBS Group
VINCU

UBS Group’s Vincerx Pharma, Inc. Unit VINCU Stock Holding History

UBS Group’s Portfolio VINCU Stock Details VINCU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-260
Closed -$7K – 9163
2021
Q1 		$7K Buy
260
+150
+136% +$4.04K ﹤0.01% 7171
2020
Q4 		$2K Buy
+110
New +$2K ﹤0.01% 7153